Form 8-K - Current report:
SEC Accession No. 0001641172-25-005078
Filing Date
2025-04-16
Accepted
2025-04-16 16:55:59
Documents
15
Period of Report
2025-04-15
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.01: Changes in Control of Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 91534
2 ex99-1.htm EX-99.1 17647
  Complete submission text file 0001641172-25-005078.txt   297869

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xtnt-20250415.xsd EX-101.SCH 3026
4 XBRL LABEL FILE xtnt-20250415_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE xtnt-20250415_pre.xml EX-101.PRE 22366
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3576
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 25843390
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)